logo
Plus   Neg
Share
Email

Marriott: Avendra To Be Sold To Aramark In $1.35 Bln Deal - Quick Facts

Marriott International (MAR), which holds 55 percent interest in Avendra LLC, announced Monday that Avendra's owners have reached a binding agreement to sell the firm to Aramark (ARMK) for $1.35 billion.

Avendra's founding shareholders, Marriott, Hyatt, Accor, ClubCorp and IHG, expect to receive approximately $1.18 billion in cash proceeds from the transaction after redemption of management participation rights, transaction costs, and repayment of Avendra's outstanding debt.

Marriott expects to receive approximately $650 million for its stake in Avendra.

Avendra was formed in 2001 through the merger of Marriott's North American procurement division with the procurement businesses and purchasing power of the other founding shareholders. At present, over half of Avendra's revenues come from providing procurement and related services to non-founders.

Marriott's original investment in Avendra totaled $13 million and was recovered from dividends from the business. Marriott committed to the owners of Marriott's hotels that the benefits derived from Avendra, including any dividends or sale proceeds above the original investment, would be used for the benefit of the hotels in its system.

The significant proceeds from the sale of Avendra to Aramark will be used over time in this manner.

Under the deal, Marriott will enter into a 5-year procurement service agreement with Aramark. While the transaction will benefit owners and franchisees of its hotels, Marriott expects the transaction will be immaterial to its financial results.

The transaction is subject to the expiration or termination of the waiting period under the Hart Scott Rodino Antitrust Improvements Act and satisfaction of other customary closing conditions. The parties expect the transaction to close before year-end.

Goldman Sachs & Co. LLC is serving as financial advisor to Avendra. Gibson Dunn is serving as legal advisor to Marriott in connection with the transaction.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration (FDA) has gone ahead with the approval of antiviral drug remdesivir as first treatment for COVID-19, notwithstanding last week's findings by the World Health Organization (WHO) that the drug is not effective for COVID-19 treatment. Thursday, Gilead Sciences announced that the FDA approved remdesivir, sold under the brand name Veklury. Integrated payments firm American Express Co. (AXP) reported Friday that net income for the third quarter declined to $1.1 billion or $1.30 per share from $1.8 billion or $2.08 per share in the prior-year quarter. Consolidated total revenues, net of interest expense, also decreased 20 percent to $8.8... The Federal Trade Commission or FTC has launched a new fraud reporting platform, using which, consumers can easily report fraud and all other consumer issues directly to the regulator. In a statement, the FTC said its new website, ReportFraud.ftc.gov, will provide a streamlined and user-friendly way to submit reports about scams, frauds, and bad business practices.
Follow RTT